Levi & Korsinsky Investigates Possible Securities Fraud Violations by Keros Therapeutics, Inc. (KROS)Accesswire • 01/29/25
Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Shareholders to Inquire about Securities InvestigationAccesswire • 01/29/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Keros Therapeutics, Inc. (KROS) And Encourages Shareholders to ConnectAccesswire • 01/28/25
Keros Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - KROSAccesswire • 01/27/25
Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Stockholders to Inquire about Securities InvestigationAccesswire • 01/27/25
Shareholder Rights Advocates at Levi & Korsinsky Investigate Keros Therapeutics, Inc. (KROS) Regarding Possible Securities Fraud ViolationsAccesswire • 01/26/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Investors to Learn More About the InvestigationAccesswire • 01/26/25
ATTENTION KROS SHAREHOLDERS: Investors who lost money on Keros Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigationAccesswire • 01/25/25
KEROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Keros Therapeutics, Inc. on Behalf of Keros Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 01/25/25
Keros Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - KROSAccesswire • 01/24/25
Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 01/24/25
Levi & Korsinsky Reminds Shareholders of an Investigation into Keros Therapeutics, Inc. (KROS) Regarding Potential Securities Fraud AllegationsAccesswire • 01/23/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Keros Therapeutics, Inc. (KROS) And Encourages Investors to ConnectAccesswire • 01/23/25
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Keros Therapeutics, Inc. (KROS)Business Wire • 01/22/25
KROS ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Keros Therapeutics, Inc. investmentAccesswire • 01/22/25
Keros Therapeutics, Inc. (KROS) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky InvestigatesAccesswire • 01/22/25
KROS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Keros Therapeutics, Inc. and Encourages Investors to Contact the FirmAccesswire • 01/22/25
Keros Therapeutics (KROS) Soars 5.1%: Is Further Upside Left in the Stock?Zacks Investment Research • 01/22/25
Keros Therapeutics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - KROSAccesswire • 01/21/25
Lost Money on Keros Therapeutics, Inc.(KROS)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 01/21/25
Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 01/21/25
Shareholders that lost money on Keros Therapeutics, Inc. (KROS) should contact Levi & Korsinsky about Securities Fraud Investigation - KROSAccesswire • 01/20/25
Down -36.23% in 4 Weeks, Here's Why Keros Therapeutics (KROS) Looks Ripe for a TurnaroundZacks Investment Research • 01/20/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 01/20/25